Tycoon Group Holdings Limited (3390.HK) AI-Powered Stock Analysis
See how Tycoon Group Holdings Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
3390.HK●HKSE
HealthcareMedical - Pharmaceuticals
HK$0.24
HK$0.00(0.00%)
Hong Kong Market opens in 38h 18m
Advertisement
Tycoon Group Holdings Limited (3390.HK)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTycoon Group Holdings Limited (3390.HK) Stock Overall Grade
Tycoon Group Holdings Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Tycoon Group Holdings Limited's overall stock rating.
Forecast
C+Score
52/100Financial Growth
CScore
40/100Fundamental Growth
B+Score
71/100Key Ratios
AScore
84/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Tycoon Group Holdings Limited (3390.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 52/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (71/100, B+) highlight its stability, while Key Ratios (84/100, A) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Tycoon Group Holdings Limited stock grade, including financials, comparisons, and forecasts.